Pharmapack 2026: We Present the Repsol Healthcare® HPP03G Grade, Our Sustainable Alternative to PVC
At Repsol, we were privileged to participate once again in Pharmapack, the leading European trade fair for pharmaceutical packaging and medical devices, held on January 21–22 in Paris as it celebrated its 25th anniversary. This year’s edition offered us the opportunity to strengthen our presence in the pharmaceutical sector, continuing a journey we have proudly sustained for eight consecutive years.
During the event, we showcased some of the most innovative solutions from the Repsol Healthcare® portfolio and, most notably, introduced a launch that represents a significant step forward in sustainability: the new HPP03G homopolymer polypropylene grade.
This material has been developed specifically for pharmaceutical blister packs used for tablets and capsules, positioning itself as a clear alternative to PVC:
As Alfonso Grande Pizarro, Senior Pharma Manager, highlighted:
“The new HPP03G grade demonstrates how innovation and circularity can go hand in hand: a 100% recyclable material that enables the development of circular packaging solutions that elevate standards across the pharmaceutical sector.”
This launch expands a portfolio that already includes 30 different grades of polypropylene, polyethylene, and EVA copolymer, enabling us to offer tailored solutions for a wide range of pharmaceutical applications.
In addition, we presented our major industrial investments in Southern Europe, which reinforce our long-term commitment to the sector—such as our Project Alba in Sines, featuring two new recyclable polymer plants, and the upcoming ultra-high molecular weight polyethylene (UHMWPE) plantv in Puertollano.
These initiatives allow us to maintain close proximity to our customers, strengthen supply continuity, and anticipate the evolving needs of a sector undergoing rapid transformation.